U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H4O2
Molecular Weight 60.052
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Acetic acid

SMILES

CC(O)=O

InChI

InChIKey=QTBSBXVTEAMEQO-UHFFFAOYSA-N
InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)

HIDE SMILES / InChI

Molecular Formula C2H4O2
Molecular Weight 60.052
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
StereoComments testing

Hydroxocobalamin (also hydroxycobalamin, OHCbl) is a natural form, or vitamer, of vitamin B12. It is a member of the cobalamin family of compounds. Hydroxocobalamin, the active ingredient in Cyanokit, is cobinamide dihydroxide dihydrogen phosphate (ester), mono (inner salt), 3’-ester with 5,6-dimethyl-1-α-D-ribofuranosyl-1H-benzimidazole. The drug substance is the hydroxylated active form of vitamin B12 and is a large molecule in which a trivalent cobalt ion is coordinated in four positions by a tetrapyrol (or corrin) ring. It is a hygroscopic, odorless, dark red, crystalline powder that is freely soluble in water and ethanol, and practically insoluble in acetone and diethyl ether. Cyanokit contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning. Cyanide is an extremely toxic poison. In the absence of rapid and adequate treatment, exposure to a high dose of cyanide can result in death within minutes due to the inhibition of cytochrome oxidase resulting in arrest of cellular respiration. Specifically, cyanide binds rapidly with cytochrome a3, a component of the cytochrome c oxidase complex in mitochondria. Inhibition of cytochrome a3 prevents the cell from using oxygen and forces anaerobic metabolism, resulting in lactate production, cellular hypoxia and metabolic acidosis. In massive acute cyanide poisoning, the mechanism of toxicity may involve other enzyme systems as well. Signs and symptoms of acute systemic cyanide poisoning may develop rapidly within minutes, depending on the route and extent of cyanide exposure. The action of Cyanokit is based on its ability to bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting it for the hydroxo ligand linked to the trivalent cobalt ion, to form cyanocobalamin, which is then excreted in the urine.

CNS Activity

Curator's Comment: Acetic acid was shown to cross the blood brain barrier in rats.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CYANOKIT

Approved Use

Cyanokit contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning. (1.1) If clinical suspicion of cyanide poisoning is high, Cyanokit should be administered without delay. (1.2) The expert advice of a regional poison control center may be obtained by calling 1-800-222-1222. (1.2) 1.1 Indication Cyanokit is indicated for the treatment of known or suspected cyanide poisoning. 1.2 Identifying Patients with Cyanide Poisoning Cyanide poisoning may result from inhalation, ingestion, or dermal exposure to various cyanide-containing compounds, including smoke from closed-space fires. Sources of cyanide poisoning include hydrogen cyanide and its salts, cyanogenic plants, aliphatic nitriles, and prolonged exposure to sodium nitroprusside. The presence and extent of cyanide poisoning are often initially unknown. There is no widely available, rapid, confirmatory cyanide blood test. Treatment decisions must be made on the basis of clinical history and signs and symptoms of cyanide intoxication. If clinical suspicion of cyanide poisoning is high, Cyanokit should be administered without delay. Table 1 Common Signs and Symptoms of Cyanide Poisoning Symptoms Signs Headache Altered Mental Status (e.g., confusion,disorientation) Confusion Seizures or Coma Dyspnea Mydriasis Chest tightness Tachypnea / Hyperpnea (early) Nausea Bradypnea / Apnea (late) Hypertension (early) / Hypotension (late) Cardiovascular collapse Vomiting Plasma lactate concentration ≥ 8 mmol/L In some settings, panic symptoms including tachypnea and vomiting may mimic early cyanide poisoning signs. The presence of altered mental status (e.g., confusion and disorientation) and/or mydriasis is suggestive of true cyanide poisoning although these signs can occur with other toxic exposures as well. The expert advice of a regional poison control center may be obtained by calling 1-800-222-1222. Smoke Inhalation Not all smoke inhalation victims will have cyanide poisoning and may present with burns, trauma, and exposure to other toxic substances making a diagnosis of cyanide poisoning particularly difficult. Prior to administration of Cyanokit, smoke-inhalation victims should be assessed for the following: Exposure to fire or smoke in an enclosed area Presence of soot around the mouth, nose or oropharynx Altered mental status Although hypotension is highly suggestive of cyanide poisoning, it is only present in a small percentage of cyanide-poisoned smoke inhalation victims. Also indicative of cyanide poisoning is a plasma lactate concentration ≥ 10 mmol/L (a value higher than that typically listed in the table of signs and symptoms of isolated cyanide poisoning because carbon monoxide associated with smoke inhalation also contributes to lactic acidemia). If cyanide poisoning is suspected, treatment should not be delayed to obtain a plasma lactate concentration. 1.3 Use with Other Cyanide Antidotes Caution should be exercised when administering other cyanide antidotes simultaneously with Cyanokit, as the safety of co-administration has not been established. If a decision is made to administer another cyanide antidote with Cyanokit, these drugs should not be administered concurrently in the same intravenous line. [see Dosage and Administration (2.3)

Launch Date

2006
Curative
VOSOL

Approved Use

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

Launch Date

1960
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
4511.6 μM × h
5 g single, intravenous
dose: 5 g
route of administration: Intravenous
experiment type: SINGLE
co-administered:
HYDROXOCOBALAMIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
26.2 h
5 g single, intravenous
dose: 5 g
route of administration: Intravenous
experiment type: SINGLE
co-administered:
HYDROXOCOBALAMIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
20 mg 1 times / day multiple, intramuscular
Dose: 20 mg, 1 times / day
Route: intramuscular
Route: multiple
Dose: 20 mg, 1 times / day
Sources:
unhealthy, 13 years
n = 1
Health Status: unhealthy
Age Group: 13 years
Sex: M
Population Size: 1
Sources:
20 g single, intravenous
Highest studied dose
Dose: 20 g
Route: intravenous
Route: single
Dose: 20 g
Sources:
unhealthy, 26.9 years
n = 1
Health Status: unhealthy
Age Group: 26.9 years
Sex: M
Population Size: 1
Sources:
5 g single, intravenous
Overdose
Dose: 5 g
Route: intravenous
Route: single
Dose: 5 g
Sources:
unhealthy, 3 years
n = 1
Health Status: unhealthy
Condition: cyanide toxicity
Age Group: 3 years
Sex: F
Population Size: 1
Sources:
5 g single, intravenous
Dose: 5 g
Route: intravenous
Route: single
Dose: 5 g
Sources:
unhealthy, 62 years
n = 1
Health Status: unhealthy
Condition: Vasoplegic Syndrome
Age Group: 62 years
Sex: M
Population Size: 1
Sources:
2000 ug 2 times / day multiple, oral
Dose: 2000 ug, 2 times / day
Route: oral
Route: multiple
Dose: 2000 ug, 2 times / day
Sources:
unhealthy, adult
n = 8
Health Status: unhealthy
Condition: pernicious anaemia
Age Group: adult
Population Size: 8
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer



Drug as perpetrator​Drug as victim

Drug as victim

Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Purification and characterization of the nocardial acetylesterase involved in 2-butanone degradation.
1974 Dec
Metabolism of resorcinylic compounds by bacteria. Purification and properties of acetylpyruvate hydrolase from Pseudomonas putida 01.
1975 May 25
Modification of drug action by hyperammonemia.
1984 Apr
Prevention of methionine and ammonia-induced coma by intravenous infusion of a branched chain amino acid solution to rats with liver injury.
1984 Oct
Disruption of the blood-brain barrier in hyperammonemic coma and the pharmacologic effects of dexamethasone and difluoromethyl ornithine.
1985
Location and sequence of the todF gene encoding 2-hydroxy-6-oxohepta-2,4-dienoate hydrolase in Pseudomonas putida F1.
1991 Jul 31
Cloning and sequencing of the gene which encodes the highly inducible acetamidase of Mycobacterium smegmatis.
1993 Mar
Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
1999 Jun 30
Conversion of 4-hydroxyacetophenone into 4-phenyl acetate by a flavin adenine dinucleotide-containing Baeyer-Villiger-type monooxygenase.
2000 Dec
Antinociceptive properties of the methanolic extract and two triterpenes isolated from Epidendrum Mosenii stems (Orchidaceae).
2000 Jan 21
Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.
2001
Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate.
2001 Apr 6
Exploring infection of wheat and carbohydrate metabolism in Mycosphaerella graminicola transformants with differentially regulated green fluorescent protein expression.
2001 Feb
Structure of manganese diacetate tetrahydrate and low-temperature methyl-group dynamics.
2001 Feb
Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.
2001 Feb
Biodistribution of radiolabeled [(3)H] CMT-3 in rats.
2001 Feb
Lipase-catalyzed irreversible transesterification of 1-(2-furyl)ethanol using isopropenyl acetate.
2001 Feb
Effect of acetate on glycogen replenishment in liver and skeletal muscles after exhaustive swimming in rats.
2001 Feb
Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions.
2001 Feb 23
Computational studies on nonenzymatic and enzymatic pyridoxal phosphate catalyzed decarboxylations of 2-aminoisobutyrate.
2001 Feb 6
Clostridium hungatei sp. nov., a mesophilic, N2-fixing cellulolytic bacterium isolated from soil.
2001 Jan
Cation-exchange purification of mutagenized bovine beta-casein expressed in transgenic mouse milk: its putative Asn68-linked glycan is heterogeneous.
2001 Jan
Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers.
2001 Jan
Immunobiology of the reproductive tract in a female baboon.
2001 Jan
Insecticidal activity of common reagents for insect foreign bodies of the ear.
2001 Jan
Physical stability of the blue pigments formed from geniposide of gardenia fruits: effects of pH, temperature, and light.
2001 Jan
N(delta)-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine, a novel methylglyoxal-arginine modification in beer.
2001 Jan
Structure and dynamics of high molecular weight glutenin subunits of durum wheat (Triticum durum) in water and alcohol solutions studied by electron paramagnetic resonance and circular dichroism spectroscopies.
2001 Jan
New analogues of bradykinin containing a conformationally restricted dipeptide fragment in their molecules.
2001 Jan
Purification and characterization of a cellulase from the ruminal fungus Orpinomyces joyonii cloned in Escherichia coli.
2001 Jan
Three types of K(+) currents in murine osteocyte-like cells (MLO-Y4).
2001 Jan
Iron-induced changes in pyruvate metabolism of Tritrichomonas foetus and involvement of iron in expression of hydrogenosomal proteins.
2001 Jan
Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate.
2001 Jan
Effects of zinc acetate on splenocytes of endotoxemic mice: enhanced immune response, reduced apoptosis, and increased expression of heat shock protein 70.
2001 Jan
Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.
2001 Jan
Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
2001 Jan
Energetics of growth and penicillin production in a high-producing strain of Penicillium chrysogenum.
2001 Jan 20
Optimised determination of clobazam in human plasma with extraction and high-performance liquid chromatography analysis.
2001 Jan 5
S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity.
2001 Jan-Feb
Salt accumulation resulting from base added for pH control, and not ethanol, limits growth of Thermoanaerobacteriumthermosaccharolyticum HG-8 at elevated feed xylose concentrations in continuous culture.
2001 Jan-Feb
Production of ethanol and xylitol from corn cobs by yeasts.
2001 Mar
Large-scale enzymatic production of natural flavour esters in organic solvent with continuous water removal.
2001 Nov 30
Ammonia-induced heme oxygenase-1 expression in cultured rat astrocytes and rat brain in vivo.
2002 Dec
Sources of oxygen radicals in brain in acute ammonia intoxication in vivo.
2003 Aug 15
Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD metabolism in nuclei of rat brain cells.
2004 Jun
[Antioxidant enzymes of the rat liver, brain, heart and erythrocytes in ammonia intoxication].
2005 Mar-Apr
Effects of acute ammonia toxicity on nitric oxide (NO), citrulline-NO cycle enzymes, arginase and related metabolites in different regions of rat brain.
2005 Oct
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates.
2009 Apr 1
Patents

Sample Use Guides

To promote continuous contact, insert a wick of cotton saturated with the drug solution (Vosol). Keep the wick in for at least 24 hours and keep it moist by adding 3 to 5 drops of solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of the drug solution 3 or 4 times daily thereafter, for as long as indicated.
Route of Administration: Otic (auricular)
In Vitro Use Guide
Curator's Comment: Hydroxocobalamin (OH-Cbl), when used to treat vitamin B12 deficiency, is better retained by the body than is cyanocobalamin (CN-Cbl), but the availability to cells has not been studied systematically. In a series of experiments, were compared the uptake and internalization of OH-Cbl and CN-Cbl bound to transcobalamin II (TCII) by a human cell model, the HeLa cell. TCII-OH-Cbl was: (1) taken up in larger amounts per unit time, (2) the greater uptake was not a consequence of more effective attachment to receptors of TCII-Cbl nor to a more rapid regeneration of receptors, (3) the difference was expressed during the phase of internalization of TCII-Cbl, (4) with CN-Cbl, the stages of binding to receptors plus internalization were more readily reversed, and (5) larger amounts of OH-Cbl were internalized and converted to active coenzyme forms of Cbl.
Acetic acid inhibited Saccharomyces cerevisiae growth. The minimum inhibitory concentration (MIC) of acetic acid for yeast growth was 0.6% w/v (100 mM).
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:07:21 GMT 2023
Edited
by admin
on Fri Dec 15 15:07:21 GMT 2023
Record UNII
Q40Q9N063P
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
Acetic acid
FHFI   II   INCI   MART.   MI   VANDF   WHO-DD   WHO-IP  
INCI  
Official Name English
ACETIC
Common Name English
ACETICUM ACIDUM [HPUS]
Common Name English
NSC-112209
Code English
NSC-127175
Code English
NSC-111201
Code English
ACIDUM ACETICUM GLACIALE
Common Name English
ACETIC ACID [JAN]
Common Name English
Acetic acid [WHO-DD]
Common Name English
ACETIC ACID [VANDF]
Common Name English
NSC-406306
Code English
ORTHOACETIC ACID
Common Name English
ACETIC ACID [MART.]
Common Name English
ACETIC ACID [II]
Common Name English
ACETIC ACID, GLACIAL COMPONENT OF BOROFAIR
Common Name English
ACETIC ACID, GLACIAL COMPONENT OF VOSOL HC
Common Name English
NSC-115870
Code English
INS NO.260
Code English
ACETIC ACID [WHO-IP]
Common Name English
ACETICUM ACIDUM
HPUS  
Common Name English
ETHANOIC ACID
Systematic Name English
ACIDUM ACETICUM [WHO-IP LATIN]
Common Name English
ACETIC ACID, GLACIAL COMPONENT OF ORLEX HC
Common Name English
INS-260
Code English
E-260
Code English
ACETIC ACID, GLACIAL COMPONENT OF ACETASOL HC
Common Name English
NSC-132953
Code English
ORLEX HC COMPONENT ACETIC ACID, GLACIAL
Common Name English
ACETIC ACID [MI]
Common Name English
ACETIC ACID, GLACIAL COMPONENT OF TRIDESILON
Common Name English
VINEGAR ACID
Common Name English
TRIDESILON COMPONENT ACETIC ACID, GLACIAL
Common Name English
VOSOL HC COMPONENT ACETIC ACID, GLACIAL
Common Name English
ACETIC ACID [FHFI]
Common Name English
ACETIC ACID [INCI]
Common Name English
ACETASOL HC COMPONENT ACETIC ACID, GLACIAL
Common Name English
FEMA NO. 2006
Code English
Classification Tree Code System Code
Food Contact Sustance Notif, (FCN No.) FCN NO. 447
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1025
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1081
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 323
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1247
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 724
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
WHO-ESSENTIAL MEDICINES LIST 28
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
WHO-ATC S02AA10
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
JECFA EVALUATION ACETIC ACID
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 879
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
NCI_THESAURUS C254
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
FDA ORPHAN DRUG 706219
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
WHO-ATC G01AD02
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
WHO-VATC QG01AD02
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1144
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
DSLD 396 (Number of products:5)
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1096
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 951
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1236
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
CFR 21 CFR 184.1005
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 908
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 728
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 993
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
CODEX ALIMENTARIUS (GSFA) INS-260
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1035
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 887
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1132
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
WHO-VATC QS02AA10
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1089
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 880
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 561
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 140
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
JECFA EVALUATION INS-260
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1082
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 801
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Food Contact Sustance Notif, (FCN No.) FCN NO. 1094
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
Code System Code Type Description
CHEBI
15366
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
WIKIPEDIA
Acetic acid (medical use)
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
406306
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
WIKIPEDIA
ACETIC ACID
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
RXCUI
168
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID5024394
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-580-7
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
RS_ITEM_NUM
1005706
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
SMS_ID
100000088999
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
DRUG CENTRAL
4211
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
WHO INTERNATIONAL PHARMACPOEIA
ACETIC ACID
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY Description: Clear, colourless liquids. At a temperature below 15 ?C Glacial acetic acid may occur as a translucent, crystalline mass; odour, characteristic and pungent. Miscibility: Miscible with water, ethanol (~750 g/l) TS, and glycerol R. Category: Acidifying agent. Storage: Acetic acid should be kept in a tightly closed container. Additional information: Glacial acetic acid is flammable and should be handled with care. Congealing point, about 15 ?C.
MESH
D019342
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
EVMPD
SUB11689MIG
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
ChEMBL
CHEMBL539
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
JECFA MONOGRAPH
3
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
PUBCHEM
176
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
127175
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
CAS
64-19-7
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NCI_THESAURUS
C61623
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
112209
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
MERCK INDEX
m1324
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY Merck Index
HSDB
39
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
132953
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
CAS
463-83-2
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
ALTERNATIVE
DAILYMED
Q40Q9N063P
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
DRUG BANK
DB03166
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
115870
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
EVMPD
SUB12711MIG
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
FDA UNII
Q40Q9N063P
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
NSC
111201
Created by admin on Fri Dec 15 15:07:22 GMT 2023 , Edited by admin on Fri Dec 15 15:07:22 GMT 2023
PRIMARY
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
PARENT -> CONSTITUENT ALWAYS PRESENT
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
PARENT -> METABOLITE
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (GC)
USP
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY